April 10, 2018 / 11:36 AM / 6 months ago

BRIEF-Mylan To Acquire The Global Marketing Rights To Glatiramer Acetate Product Through An Investment And Partnership With Israeli Company Mapi Pharma

April 10 (Reuters) - Mylan NV:

* MYLAN TO ACQUIRE THE GLOBAL MARKETING RIGHTS TO A ONCE-MONTHLY GLATIRAMER ACETATE PRODUCT THROUGH AN INVESTMENT AND PARTNERSHIP WITH ISRAELI COMPANY MAPI PHARMA

* CO, MAPI PHARMA TO PARTNER ON DEVELOPMENT & COMMERCIALIZATION OF GA DEPOT, A LONG-ACTING GLATIRAMER ACETATE PRODUCT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below